Aurobindo Pharmaceuticals

Rediff.com » News » Aurobindo Pharmaceuticals

News for Aurobindo Pharmaceuticals

News
Business
Sports

How companies show electoral donations in annual reports

A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit. Illustration:......

More Covid vaccine candidates get approval for clinical trials in India

Ahmedabad-based Zydus Cadila, Bharat Biotech’s intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.......

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......

Are Indian Markets Overstretched?

The index is currently trading at 149 per cent of its historical P/B valuation, surpassing its previous peak of 125 per cent made in 2020-21. Illustration: Dominic Xavier/Rediff.com Indian......

Aurobindo Pharma: Strong prospects offset by valuation concerns

Since the start of this financial year (FY24), the stock of Aurobindo Pharma has been one of the top pharma gainers, enhancing investor wealth by over 68 per cent, with a third of those gains......

US drug shortage, stable pricing set to boost pharma revenues

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India’s pharmaceutical companies during the first quarter of this financial......

Adani, Goenka could lead the charge at IPL team bidding

IMAGE: There are 22 companies which have picked up tender document worth Rs 10 lakh but with base price for new teams pegged at Rs 2000 crore,......

Rediff News

Aurobindo Pharmaceuticals

News for Aurobindo Pharmaceuticals

How companies show electoral donations in annual reports

More Covid vaccine candidates get approval for clinical trials in India

Lower input costs may aid pharma firms' Q2 margins

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Are Indian Markets Overstretched?

Aurobindo Pharma: Strong prospects offset by valuation concerns

US drug shortage, stable pricing set to boost pharma revenues

Adani, Goenka could lead the charge at IPL team bidding

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS